PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for February 14, 2007 Subscribe to this News Feed    
 

Current Advances in the Field of Synthetic Biology to be Addressed at Synthetic Biology: Transforming Life Science Research & Discovery Conference & Exhibition

Beachhead Consulting and Informa Learning have created the Synthetic Biology Conference and Exhibition. This forum is designed for researchers and executives working in synthetic and systems biology technology and product development to discuss how their research can be applied to life sciences. Sessions will cover current advances in the field of synthetic biology and how these can be applied to benefit pharmaceutical and biotechnical manufacturers at many different levels.

Westborough, MA (PRWEB) February 14, 2007 -- Beachhead Consulting and Informa Learning have created the Synthetic Biology Conference and Exhibition. This forum is designed for researchers and executives working in synthetic and systems biology technology and product development to discuss how their research can be applied to life sciences.

The Synthetic Biology keynote presentation will cover advances in technologies of biological information:

Keynote Speaker:
Noubar B. Afeyan, Ph.D., Flagship Ventures
Engineering Biological Systems:
Advances in Technologies for Reading, Modeling, Simulating and Writing of Biological Information.

Sessions will cover current advances in the field of synthetic biology and how these can be applied to benefit pharmaceutical and biotechnical manufacturers at many different levels.

Major Sessions:

 
  • Foundational Technology
  • This session will cover how synthetic biologists change the behavior of the cell by designing and rewiring the complex networks of genes inside the cell.
  • Protein Engineering
  • This session will discuss a few of the many different aspects of protein engineering.
  • Metabolic Engineering
  • This session discusses modeling efforts and technologies involved in programming and controlling metabolic pathways to produce biological substitutes for less desirable chemical processes.
  • Therapeutic Engineering
  • This session will present modeling efforts and cellular engineering efforts to develop better methods for drug development and delivery.
  • Cellular and Tissue Engineering
  • This session presents methods to model cellular behavior for successive synthetic biology approaches.
  • Government, Business and Regulatory Issues
This session will present current efforts within the synthetic biology community to produce standards for development and guidelines, centered around the efforts of a newly established international consortium on polynucleotide synthesis.

Synthetic Biology exhibit hall includes 5 companies in the field of synthetic biology. They are: sponsor and exhibitor Codon Devices & exhibitors BlueHeron Biotechnology, DNA 2.0, GENEART, and The Mathworks.

For questions contact IBC Life Sciences, 800.390.4078 or visit the website at http://www.IBCLifeSciences.com/synthetic.

To review the agenda, visit http://www.IBCLifeSciences.com/synthetic

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/WmV0YS1Qcm9mLVBpZ2ctSG9yci1NYWduLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareThis
CONTACT INFORMATION
Steve Garofalo
IBC Life Sciences
(508)614-1235
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move